Google DeepMind CEO Sir Demis Hassabis, fresh off his 2024 Nobel Prize in Chemistry, predicts a transformative decade ahead for artificial intelligence. Speaking with Fortune, the Nobel laureate described an impending "new golden era of discovery" that will revolutionize medicine, energy, and space exploration, but only after navigating a challenging 10-15 year transition period.

This vision drove Google's 2023 reorganization merging Google Brain and DeepMind into a unified AI powerhouse under Hassabis' leadership. The consolidation pooled "enormous compute power" to train frontier models like Gemini, which helped Alphabet shares surge approximately 65% following releases of models including Gemini 3 and the viral image generator "Nano Banana." Hassabis views this restructuring as essential to avoid disruption from competitors like OpenAI's ChatGPT.

The cornerstone of this AI-driven renaissance is AlphaFold, DeepMind's breakthrough that solved the 50-year protein folding problem and now serves over 3 million researchers worldwide. At Google spin-off Isomorphic Labs, Hassabis is applying this technology to drug discovery, claiming the process can become "1,000 times more efficient" through computer simulation rather than traditional wet labs. With cancer drug trials approaching clinical stages, Hassabis maintains his grueling schedule—working from 10 p.m. to 4 a.m. daily—believing the ultimate prize justifies the intense technological shakeout ahead.